Australia markets close in 5 hours 18 minutes

BeiGene, Ltd. (BGNE)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
162.58-3.80 (-2.28%)
At close: 04:00PM EDT
162.58 0.00 (0.00%)
After hours: 04:32PM EDT
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
2,762,630
2,458,779
1,415,921
1,176,283
308,874
Cost of revenue
423,066
379,920
286,475
164,906
70,657
Gross profit
2,339,564
2,078,859
1,129,446
1,011,377
238,217
Operating expenses
Research development
1,830,648
1,778,594
1,640,508
1,459,239
1,294,877
Selling general and administrative
1,603,429
1,504,501
1,277,852
990,123
600,176
Total operating expenses
3,437,390
3,286,595
2,919,111
2,450,112
1,895,899
Operating income or loss
-1,097,826
-1,207,736
-1,789,665
-1,438,735
-1,657,682
Total other income/expenses net
291,350
307,891
-223,852
15,904
37,490
Income before tax
-732,323
-825,836
-1,961,037
-1,438,588
-1,618,194
Income tax expense
52,104
55,872
42,778
19,228
10,397
Income from continuing operations
-784,427
-881,708
-2,003,815
-1,457,816
-1,628,591
Net income
-784,427
-881,708
-2,003,815
-1,457,816
-1,624,974
Net income available to common shareholders
-784,427
-881,708
-2,003,815
-1,457,816
-1,624,974
Basic EPS
-9.23
-8.45
-19.37
-15.21
-19.11
Diluted EPS
-9.23
-8.45
-19.37
-15.21
-19.11
Basic average shares
104,311
104,387
103,133
92,785
83,472
Diluted average shares
104,311
104,387
103,133
92,785
83,472